Bristol-Myers Squibb
BMY
$58.90
Share price
-0.30%
Change (1 day)
-16.70%
Change (1 year)
Categories
Earnings for Bristol-Myers Squibb (BMY)
Earnings in 2023 (TTM): $8.69 B
According to Bristol-Myers Squibb's latest financial reports the company's current earnings (TTM) are $8.69 B. In 2022 the company made an earning of $7.71 B a decrease over its 2021 earnings that were of $8.09 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Bristol-Myers Squibb from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $8.69 B | 12.76% |
| 2022 | $7.71 B | -4.75% |
| 2021 | $8.09 B | -217.86% |
| 2020 | -$6.88 B | -238.11% |
| 2019 | $4.97 B | -17.22% |
| 2018 | $6.01 B | 17.13% |
| 2017 | $5.13 B | -13.25% |
| 2016 | $5.91 B | 172.96% |
| 2015 | $2.16 B | -8.99% |
| 2014 | $2.38 B | -17.64% |
| 2013 | $2.89 B | 23.55% |
| 2012 | $2.34 B | -66.48% |
| 2011 | $6.98 B | 14.99% |
| 2010 | $6.07 B | 8.37% |
| 2009 | $5.60 B | 0.86% |
| 2008 | $5.55 B | 57.16% |
| 2007 | $3.53 B | 34.12% |
| 2006 | $2.63 B | -41.65% |
| 2005 | $4.51 B | 2.22% |
| 2004 | $4.41 B | -5.88% |
| 2003 | $4.69 B | 133.53% |
| 2002 | $2.01 B | -30.59% |
| 2001 | $2.89 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $24.83 B | 185.58% | 🇺🇸 USA |
 Novartis NVS | $9.16 B | 5.43% | 🇨🇭 Switzerland |
 Pfizer PFE | $24.22 B | 178.50% | 🇺🇸 USA |
 AbbVie ABBV | $10.45 B | 20.16% | 🇺🇸 USA |
 Eli Lilly LLY | $7.28 B | -16.29% | 🇺🇸 USA |
 Amgen AMGN | $9.19 B | 5.74% | 🇺🇸 USA |
 Sanofi SNY | $9.96 B | 14.55% | 🇫🇷 France |
 Biogen BIIB | $3.12 B | -64.11% | 🇺🇸 USA |
 Merck MRK | $6.38 B | -26.56% | 🇺🇸 USA |
 AstraZeneca AZN | $7.54 B | -13.25% | 🇬🇧 UK |